GUIDED THERAPEUTICS INC (108)
Browse by Contract Category
Contracts
-
Amendment #1 to Exchange Agreement between the Company and Auctus Fund, LLC
(Filed With SEC on November 14, 2022)
-
Form of Warrants issued to Auctus Fund, LLC
(Filed With SEC on September 15, 2022)
-
Consulting Agreement with Richard Blumberg, dated as of March 11, 2021
(Filed With SEC on April 7, 2021)
-
Lease Modification, dated as of February 23, 2018, by and between Guided Therapeutics, Inc. and TREA Infill Industrial Atlanta, LLC
(Filed With SEC on April 20, 2020)
-
License Agreement Modification, dated as of July 24, 2019, by and between Guided Therapeutics, Inc. and Shandong Medical Instrument Corporation
(Filed With SEC on April 20, 2020)
-
Form of Warrants issued to Auctus Fund, LLC
(Filed With SEC on September 15, 2022)
-
Exchange Agreement between the Company and Auctus Fund, LLC
(Filed With SEC on September 15, 2022)
-
Form Securities Purchase Agreement
(Filed With SEC on September 15, 2022)
-
Form of Warrant
(Filed With SEC on September 15, 2022)
-
Form of Warrant
(Filed With SEC on September 15, 2022)
-
Form of Public Warrant
(Filed With SEC on July 13, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on June 30, 2022)
-
Form of Warrant Agency Agreement
(Filed With SEC on June 30, 2022)
-
EXCHANGE AGREEMENT
(Filed With SEC on June 30, 2022)
-
Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Gene S. Cartwright
(Filed With SEC on March 30, 2022)
-
Form of Common Stock Purchase Warrant (Aspen Capital) dated May 31, 2021
(Filed With SEC on March 30, 2022)
-
Form of Common Stock Purchase Warrant (Iron Stone Capital) dated August 10, 2021
(Filed With SEC on March 30, 2022)
-
Form of Common Stock Purchase Warrant dated November 4, 2021
(Filed With SEC on March 30, 2022)
-
Agreement dated September 30, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and John Gould
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 13, 2021, by and between Guided Therapeutics, Inc. and Frederick Grimm
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg, Esq
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and K2 Medical, LLC
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 10, 2021, by and between Guided Therapeutics, Inc. and John Imhoff, M.D
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Mark L. Faupel
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II LLC
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Michael C. James
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Bryan Mamula
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Flynn D. Case Living Trust
(Filed With SEC on March 30, 2022)
-
Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Dolores Maloof
(Filed With SEC on March 30, 2022)
-
Promissory Note, dated December 31, 2021, by and between Guided Therapeutics, Inc. and William Wells
(Filed With SEC on March 30, 2022)
-
EXCHANGE AGREEMENT
(Filed With SEC on March 30, 2022)
-
Exchange Agreement dated February 1, 2022, by and between Guided Therapeutics, Inc. and Auctus Fund LLC
(Filed With SEC on March 30, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 17, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on February 17, 2022)
-
Form of Public Warrant
(Filed With SEC on February 17, 2022)
-
Exchange Agreement, dated as of June 23, 2020, by and between Guided Therapeutics, Inc. and James Clavijo
(Filed With SEC on February 17, 2022)
-
Amendment to the Agreement by and between Guided Therapeutics Inc. and Shandong Yaohua Medical Instrument Corporation, dated August 12, 2021
(Filed With SEC on September 7, 2021)
-
Form of Acknowledgement
(Filed With SEC on June 10, 2021)
-
Securities Purchase Agreement with Auctus, dated as of May 27, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Manju Venugopal), dated August 10, 2020
(Filed With SEC on April 7, 2021)
-
Note Payable Agreement with Gene Cartwright, dated February 19, 2021
(Filed With SEC on April 7, 2021)
-
Note Payable Agreement with Mark Faupel, dated February 19, 2021
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Aspen Capital), dated June 23, 2020
(Filed With SEC on April 7, 2021)
-
Finders Fee Agreement with JH Darbie, dated as of May 19, 2020
(Filed With SEC on April 7, 2021)
-
Debt for Equity Exchange Agreement with Auctus, dated as of May 22, 2020
(Filed With SEC on April 7, 2021)
-
Securities Purchase Agreement (Series F), dated March 31, 2020
(Filed With SEC on April 7, 2021)
-
Finders Fee Agreement with FCMI, dated as of June 11, 2020
(Filed With SEC on April 7, 2021)
-
Exchange Agreement with William Wells, dated as of July 9, 2020
(Filed With SEC on April 7, 2021)
-
Securities Purchase Agreement with PowerUp, dated as of December 24, 2020
(Filed With SEC on April 7, 2021)
-
Securities Purchase Agreement with PowerUp, dated as of February 10, 2021
(Filed With SEC on April 7, 2021)
-
Exchange Agreement with Richard Fowler, dated as of March 22, 2021
(Filed With SEC on April 7, 2021)
-
Securities Purchase Agreement (Series E), dated June 30, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Credential Qtrade Securities Inc. ITF Reve Royalty Income Growth, dated as of June 23, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (James Clavijo), dated June 23, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Auctus Note), dated May 22, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Series D Preferred Stock)
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Series D Preferred Stock)
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Auctus Note), dated March 31, 2020
(Filed With SEC on April 7, 2021)
-
Convertible Promissory Note with Auctus, dated March 31, 2020
(Filed With SEC on April 7, 2021)
-
Form of Warrant (Ironstone Capital), dated April 23, 2020
(Filed With SEC on April 7, 2021)
-
Common Stock Warrant, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of April 30, 2018, by and between Guided Therapeutics, Inc. and Power Up
(Filed With SEC on April 20, 2020)
-
Purchase and Sale Agreement, dated as of February 14, 2019, by and between Guided Therapeutics, Inc. and Everest Business Funding
(Filed With SEC on April 20, 2020)
-
Equity Financing Agreement, dated as of March 1, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel
(Filed With SEC on April 20, 2020)
-
Promissory Note, dated as of September 19, 2018, by and between Guided Therapeutics, Inc. and Mr. Gould
(Filed With SEC on April 20, 2020)
-
Promissory Note, dated as of August 22, 2018, by and between Guided Therapeutics, Inc. and Mr. Case
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of July 3, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of June 22, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of June 7, 2018, by and between Guided Therapeutics, Inc. and Power Up
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of March 12, 2018, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of March 20, 2018, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of May 17, 2018, by and between Guided Therapeutics, Inc. and GHS Investments, Inc
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of March 29, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of February 22, 2018, by and between Guided Therapeutics, Inc. and Power Up
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of February 12, 2018, by and between Guided Therapeutics, Inc. and Adar Bays, LLC
(Filed With SEC on April 20, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on April 20, 2020)
-
Form of Warrant (Exchange Agreements)
(Filed With SEC on April 20, 2020)
-
Form of 12% debenture
(Filed With SEC on April 20, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on April 20, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on April 20, 2020)
-
Promissory Note, dated as of February 15, 2019, by and between Guided Therapeutics, Inc. and Mr. Gould
(Filed With SEC on April 20, 2020)
-
Loan Agreement, dated as of July 1, 2019, by and between Guided Therapeutics, Inc. and Accilent Capital Management Inc. / Rev Royalty Trust Income and Growth Trust
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Eagle Equities, LLC
(Filed With SEC on April 20, 2020)
-
Form of Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Investors
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of March 31, 2020, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Promotional Agreement, dated as of January 22, 2020, by and between Guided Therapeutics, Inc. and Blumberg & Bowles Consulting, LLC
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of January 16, 2020, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II, LLC
(Filed With SEC on April 20, 2020)
-
Promissory Note, dated as of January 15, 2020, by and between Guided Therapeutics, Inc. and IRTH Communications, LLC
(Filed With SEC on April 20, 2020)
-
Finders Fee Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Iron Stone Capital
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Dr. Imhoff
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of January 6, 2020, by and between Guided Therapeutics, Inc. and Jones Day Law Firm
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and Mr. Blumberg
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of December 30, 2019, by and between Guided Therapeutics, Inc. and K2
(Filed With SEC on April 20, 2020)
-
Form of Joinder Agreement (Series D), dated December 30, 2019
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of May 15, 2019, by and between Guided Therapeutics, Inc. and Adar Bays, LLC
(Filed With SEC on April 20, 2020)
-
Registration Rights Agreement (Series D), dated December 30, 2019
(Filed With SEC on April 20, 2020)
-
Form of Security Agreement between the Guided Therapeutics, Inc. and investors set forth therein
(Filed With SEC on April 20, 2020)
-
Form of Securities Purchase Agreement between the Guided Therapeutics, Inc. and investors set forth therein
(Filed With SEC on April 20, 2020)
-
Registration Rights Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Security Agreement, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Securities Purchase Agreement, dated as of December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)
-
Exchange Agreement, dated as of December 5, 2019, by and between Guided Therapeutics, Inc. and Aquarius
(Filed With SEC on April 20, 2020)
-
Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Cartwright
(Filed With SEC on April 20, 2020)
-
Addendum to the Exchange Agreement, dated as of September 30, 2018, by and between Guided Therapeutics, Inc. and Dr. Faupel
(Filed With SEC on April 20, 2020)
-
Senior Secured Convertible Note, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC
(Filed With SEC on April 20, 2020)